ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors

NCT00132158 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Rhabdomyosarcomas
Neuroblastoma
Osteosarcoma

Interventions

DRUG: Irinotecan (Camptosar), Gefitinib (Iressa)

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]